melatonin has been researched along with mirtazapine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Checkley, S; Palazidou, E; Papadopoulos, A; Sitsen, A; Stahl, S | 1 |
Brunner, H; Held, K; Ising, M; Schmid, DA; Sonntag, A; Steiger, A; Uhr, M; Weikel, JC; Wichniak, A | 1 |
Dolev, Z | 1 |
Osler, M; Rosenqvist, TW; Wium-Andersen, IK; Wium-Andersen, MK | 1 |
1 trial(s) available for melatonin and mirtazapine
Article | Year |
---|---|
Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Topics: Adrenocorticotropic Hormone; Adult; Animals; Antidepressive Agents, Tricyclic; Area Under Curve; Body Weight; Circadian Rhythm; Depression; Dexamethasone; Dose-Response Relationship, Drug; Electroencephalography; Endocrine System; Female; Ghrelin; Growth Hormone; Hormones; Humans; Hydrocortisone; Immunoradiometric Assay; Leptin; Male; Melatonin; Mianserin; Middle Aged; Mirtazapine; Peptide Hormones; Prolactin; Psychometrics; Sleep; Time Factors | 2006 |
4 other study(ies) available for melatonin and mirtazapine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man.
Topics: Adrenergic alpha-Antagonists; Adult; Circadian Rhythm; Humans; Male; Melatonin; Mianserin; Mirtazapine | 1989 |
Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
Topics: Antidepressive Agents, Tricyclic; Body Weight; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Melatonin; Mianserin; Middle Aged; Mirtazapine; Perimenopause; Quality of Life; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2011 |
Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study.
Topics: Benzodiazepines; Denmark; Drug Prescriptions; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Male; Melatonin; Mianserin; Mirtazapine; Olanzapine; Pregabalin; Promethazine; Quetiapine Fumarate; Substance-Related Disorders | 2023 |